These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19890495)

  • 1. Selective natural kappa opioid and cannabinoid receptor agonists with a potential role in the treatment of gastrointestinal dysfunction.
    Fichna J; Schicho R; Janecka A; Zjawiony JK; Storr M
    Drug News Perspect; 2009 Sep; 22(7):383-92. PubMed ID: 19890495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Salvinorin A and related diterpenes--biological activity and potential therapeutic uses].
    Piekielna J; Fichna J; Janecka A
    Postepy Biochem; 2012; 58(4):485-91. PubMed ID: 23662442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From local to global-fifty years of research on Salvia divinorum.
    Casselman I; Nock CJ; Wohlmuth H; Weatherby RP; Heinrich M
    J Ethnopharmacol; 2014 Feb; 151(2):768-83. PubMed ID: 24315983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating kappa-opioid and cannabinoid receptors.
    Fichna J; Schicho R; Andrews CN; Bashashati M; Klompus M; McKay DM; Sharkey KA; Zjawiony JK; Janecka A; Storr MA
    Neurogastroenterol Motil; 2009 Dec; 21(12):1326-e128. PubMed ID: 19650775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological activity of salvinorin A, the major component of Salvia divinorum.
    Listos J; Merska A; Fidecka S
    Pharmacol Rep; 2011; 63(6):1305-9. PubMed ID: 22358078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics.
    Cruz A; Domingos S; Gallardo E; Martinho A
    Phytochemistry; 2017 May; 137():9-14. PubMed ID: 28190678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic studies of neoclerodane diterpenes from Salvia divinorum: preparation and opioid receptor activity of salvinicin analogues.
    Simpson DS; Katavic PL; Lozama A; Harding WW; Parrish D; Deschamps JR; Dersch CM; Partilla JS; Rothman RB; Navarro H; Prisinzano TE
    J Med Chem; 2007 Jul; 50(15):3596-603. PubMed ID: 17580847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.
    Roth BL; Baner K; Westkaemper R; Siebert D; Rice KC; Steinberg S; Ernsberger P; Rothman RB
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11934-9. PubMed ID: 12192085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New neoclerodane diterpenoids isolated from the leaves of Salvia divinorum and their binding affinities for human kappa opioid receptors.
    Lee DY; Ma Z; Liu-Chen LY; Wang Y; Chen Y; Carlezon WA; Cohen B
    Bioorg Med Chem; 2005 Oct; 13(19):5635-9. PubMed ID: 16084728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.
    Chavkin C; Sud S; Jin W; Stewart J; Zjawiony JK; Siebert DJ; Toth BA; Hufeisen SJ; Roth BL
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1197-203. PubMed ID: 14718611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and chemical modification of clerodane diterpenoids from Salvia species as potential agonists at the kappa-opioid receptor.
    Li Y; Husbands SM; Mahon MF; Traynor JR; Rowan MG
    Chem Biodivers; 2007 Jul; 4(7):1586-93. PubMed ID: 17638340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinociceptive and hypothermic effects of Salvinorin A are abolished in a novel strain of kappa-opioid receptor-1 knockout mice.
    Ansonoff MA; Zhang J; Czyzyk T; Rothman RB; Stewart J; Xu H; Zjwiony J; Siebert DJ; Yang F; Roth BL; Pintar JE
    J Pharmacol Exp Ther; 2006 Aug; 318(2):641-8. PubMed ID: 16672569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kappa-opioid receptor-selective dicarboxylic ester-derived salvinorin A ligands.
    Polepally PR; White K; Vardy E; Roth BL; Ferreira D; Zjawiony JK
    Bioorg Med Chem Lett; 2013 May; 23(10):2860-2. PubMed ID: 23587424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues.
    Riley AP; Groer CE; Young D; Ewald AW; Kivell BM; Prisinzano TE
    J Med Chem; 2014 Dec; 57(24):10464-75. PubMed ID: 25426797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvinorin A content in legal high products of Salvia divinorum sold in Mexico.
    Hernández-Bello R; García-Rodríguez RV; García-Sosa K; Peña-Rodríguez LM; Vázquez-Hernández M; Ramos-Morales FR; Corcoran O; Sánchez-Medina A
    Forensic Sci Int; 2015 Apr; 249():197-201. PubMed ID: 25710779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors.
    Capasso R; Borrelli F; Cascio MG; Aviello G; Huben K; Zjawiony JK; Marini P; Romano B; Di Marzo V; Capasso F; Izzo AA
    Br J Pharmacol; 2008 Nov; 155(5):681-9. PubMed ID: 18622408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic studies of neoclerodane diterpenes from Salvia divinorum: semisynthesis of salvinicins A and B and other chemical transformations of salvinorin A.
    Harding WW; Schmidt M; Tidgewell K; Kannan P; Holden KG; Gilmour B; Navarro H; Rothman RB; Prisinzano TE
    J Nat Prod; 2006 Jan; 69(1):107-12. PubMed ID: 16441078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents.
    Braida D; Capurro V; Zani A; Rubino T; Viganò D; Parolaro D; Sala M
    Br J Pharmacol; 2009 Jul; 157(5):844-53. PubMed ID: 19422370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvinorin a and related compounds as therapeutic drugs for psychostimulant-related disorders.
    dos Santos RG; Crippa JA; Machado-de-Sousa JP; Hallak JE
    Curr Drug Abuse Rev; 2014; 7(2):128-32. PubMed ID: 25563442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvia divinorum: from Mazatec medicinal and hallucinogenic plant to emerging recreational drug.
    Zawilska JB; Wojcieszak J
    Hum Psychopharmacol; 2013 Sep; 28(5):403-12. PubMed ID: 23794315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.